Physician profile
Berhane Wubshet
NPI 1013963297
$2,241.81
in general payments reported to CMS, 2019-2025
9 companies · $1,122 in 2025
The $1,122 reported for 2025 was more than what 86% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $184 · 2024: $937 · 2025: $1,122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,241.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $904.59 | 2024-2025 | Aveir, Optis, Gallant |
| Boston Scientific Corporation | $482.49 | 2024-2025 | Avvigo Guidance System, General - Therapies |
| Shockwave Medical, INC | $315.56 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Neurocrine Biosciences, INC. | $187.71 | 2023-2024 | Ingrezza |
| Teleflex LLC | $134.24 | 2025 | Orsiro Mission |
| Medtronic, INC. | $110.33 | 2025 | Closurefast |
| Lilly USA, LLC | $53.46 | 2025 | Zepbound, Mounjaro |
| Emd Serono, INC. | $33.56 | 2023 | Serostim |
| Fresenius USA Marketing, INC. | $19.87 | 2024 | Velphoro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Berhane Wubshet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.